Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Vaxart Inc (VXRT)

NASDAQ
Currency in USD
Disclaimer
0.6584
-0.0513(-7.23%)
Closed
Pre Market
0.6807+0.0223(+3.39%)

VXRT Comments

This is from : "A medical graduate here who knows a thing or two about trials. Double checked with my friend who is heavily vested in research. Vaxart is conducting and trials have different phases. The purpose of this phase, phase 1 is only to ensure that the vaccine is safe. That it does not cause any harm to the person.....which it achieved (also says so in their study that this is the purpose of phase 1.) The market is overreacting. The purpose was never to find antibodies as the people who enrolled into this phase are healthy people. This is what happens when the media takes a statement and misrepresents it."
true. idk of they will enter phase 2 but maybe the higher doses will elicit a better immune response. but they are very very behind to the race to the vaccine.
 VXRT can save third world countries.
not only that alot of dev. countried need and also the common flu too, its just they are very behind.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.